Investor’s Toolkit: Key Ratios for Assessing Encompass Health Corp (EHC)’s Performance

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

Encompass Health Corp (NYSE: EHC) closed the day trading at $118.88 down -1.28% from the previous closing price of $120.42. In other words, the price has decreased by -$1.28 from its previous closing price. On the day, 0.82 million shares were traded. EHC stock price reached its highest trading level at $119.82 during the session, while it also had its lowest trading level at $117.855.

Ratios:

For a better understanding of EHC, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 71.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.01. For the most recent quarter (mrq), Quick Ratio is recorded 1.06 and its Current Ratio is at 1.06. In the meantime, Its Debt-to-Equity ratio is 1.25 whereas as Long-Term Debt/Eq ratio is at 1.18.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, KeyBanc Capital Markets on October 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $115.

On July 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $100.

On March 06, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $95.Barclays initiated its Overweight rating on March 06, 2024, with a $95 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 20 ’25 when Tarr Mark J sold 118,384 shares for $121.53 per share. The transaction valued at 14,387,152 led to the insider holds 527,070 shares of the business.

Mark Tarr bought 118,384 shares of EHC for $14,383,656 on May 20 ’25. On May 06 ’25, another insider, Charbonneau Elissa Joy, who serves as the Chief Medical Officer of the company, sold 4,279 shares for $116.61 each. As a result, the insider received 498,974 and left with 11,958 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EHC now has a Market Capitalization of 11982746624 and an Enterprise Value of 15746227200. As of this moment, Encompass’s Price-to-Earnings (P/E) ratio for their current fiscal year is 24.54, and their Forward P/E ratio for the next fiscal year is 21.28. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.17. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.17 while its Price-to-Book (P/B) ratio in mrq is 5.56. Its current Enterprise Value per Revenue stands at 2.856 whereas that against EBITDA is 12.776.

Stock Price History:

The Beta on a monthly basis for EHC is 0.89, which has changed by 0.39448678 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, EHC has reached a high of $123.13, while it has fallen to a 52-week low of $82.74. The 50-Day Moving Average of the stock is 0.62%, while the 200-Day Moving Average is calculated to be 15.46%.

Shares Statistics:

Over the past 3-months, EHC traded about 858.18K shares per day on average, while over the past 10 days, EHC traded about 741080 shares per day. A total of 100.90M shares are outstanding, with a floating share count of 99.28M. Insiders hold about 1.50% of the company’s shares, while institutions hold 96.59% stake in the company. Shares short for EHC as of 1749772800 were 844312 with a Short Ratio of 0.98, compared to 1747267200 on 1214677. Therefore, it implies a Short% of Shares Outstanding of 844312 and a Short% of Float of 0.9400000000000001.

Dividends & Splits

EHC’s forward annual dividend rate is 0.68, up from 0.66 a year ago. Against a Trailing Annual Dividend Yield of 0.0054808175The stock’s 5-year Average Dividend Yield is 1.24. The current Payout Ratio is 14.35% for EHC, which recently paid a dividend on 2025-07-01 with an ex-dividend date of 1751328000. Stock splits for the company last occurred on 2022-07-01 when the company split stock in a 1257:1000 ratio.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.